Chicago Capital Management, LLC Quant / Systematic

Location: Chicago, IL

CIK: 0001580162 · Show all filings

Period: Q3 2020 (← Previous) (Next →)

Filing Date: Nov 6, 2020

Total Value: $104M (100.0% shares, 0.0% debt)

Holdings (15)

— LIVONGO HEALTH INC 18.0%
Value $18.84M Shares 134,542 Share Price $140.05 Est. Cost/Share $140.05 Unrealized @ Report Date —
— MOMENTA PHARMACEUTICALS INC 17.1%
Value $17.84M Shares 339,883 Share Price $52.50 Est. Cost/Share $52.50 Unrealized @ Report Date —
— NATIONAL GEN HLDGS CORP 15.5%
Value $16.18M Shares 479,284 Share Price $33.75 Est. Cost/Share $33.75 Unrealized @ Report Date —
— AIMMUNE THERAPEUTICS INC 13.7%
Value $14.28M Shares 414,500 Share Price $34.45 Est. Cost/Share $34.45 Unrealized @ Report Date —
— IMMUNOMEDICS INC 12.0%
Value $12.5M Shares 147,000 Share Price $85.03 Est. Cost/Share $85.03 Unrealized @ Report Date —
— VIVINT SOLAR INC 6.1%
Value $6.346M Shares 149,852 Share Price $42.35 Est. Cost/Share $42.35 Unrealized @ Report Date —
— BMC STK HLDGS INC 5.4%
Value $5.645M Shares 131,806 Share Price $42.83 Est. Cost/Share $42.83 Unrealized @ Report Date —
— ROSETTA STONE INC 5.4%
Value $5.636M Shares 187,976 Share Price $29.98 Est. Cost/Share $29.98 Unrealized @ Report Date —
— STANDARD AVB FINL CORP 3.5%
Value $3.699M Shares 113,301 Share Price $32.65 Est. Cost/Share $32.65 Unrealized @ Report Date —
DVN DEVON ENERGY CORP NEW 1.3%
Value $1.343M Shares 141,998 Share Price $9.46 * Est. Cost/Share $7.91 Unrealized @ Report Date -8.3%
— JERNIGAN CAP INC 0.7%
Value $745K Shares 43,487 Share Price $17.13 Est. Cost/Share $17.13 Unrealized @ Report Date —
— AKCEA THERAPEUTICS INC 0.7%
Value $688K Shares 37,931 Share Price $18.14 Est. Cost/Share $18.14 Unrealized @ Report Date —
— BRIDGE BANCORP INC 0.3%
Value $363K Shares 20,804 Share Price $17.45 Est. Cost/Share $17.45 Unrealized @ Report Date —
— MVC CAP INC 0.3%
Value $273K Shares 35,000 Share Price $7.80 Est. Cost/Share $7.80 Unrealized @ Report Date —
— DELPHI TECHNOLOGIES PL 0.0%
Value $49,000 Shares 2,904 Share Price $16.87 Est. Cost/Share $7.92 Unrealized @ Report Date —